High Court Won’t Hear InFuse Off-Label Preemption Case
This article was originally published in The Gray Sheet
Executive Summary
The case would have tested whether manufacturers could be held liable if an FDA-approved device injured a patient when the product was employed for an off-label, unapproved use. The Oklahoma Federal Court and the 10th Circuit Court of Appeals had both previously ruled in industry’s favor.
You may also be interested in...
Unlocking Legalities: Gorsuch’s Impact May Be Felt On Free Speech, Preemption
Supreme Court Nominee Judge Neil Gorsuch has ruled favoring device companies on preemption, and in support of an inventor in a device patent case. But experts say the impact he would actually have on the court remains to be seen.
Cervical Spine Bone Graft Gains FDA Go-Ahead
Cerapedics' i-Factor peptide-enhanced bone graft will be used to treat degenerative cervical disc disease, the first bone graft product PMA-approved for that indication, the company says.
Another Medtronic Preemption Case Appealed to High Court
A case questioning whether patients can sue device makers if a PMA-approved device is marketed for off-label uses may be headed to the Supreme Court, following a recent petition for a writ of certiorari.